[go: up one dir, main page]

Faull et al., 2001 - Google Patents

HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration

Faull et al., 2001

View HTML
Document ID
15966101176213109785
Author
Faull R
Stanley J
Fraser S
Power D
Leavesley D
Publication year
Publication venue
Kidney international

External Links

Snippet

HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Background The mesothelial cell monolayer lining the peritoneal membrane needs constant repair in response to peritonitis and to the toxicity of peritoneal dialysate. In …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Faull et al. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration
Tseng et al. Suppression of transforming growth factor‐beta isoforms, TGF‐β receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix
JP4046358B2 (en) Submucosa extract
Jain et al. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.
Fenjves et al. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy.
Alitalo et al. Extracellular matrix components synthesized by human amniotic epithelial cells in culture
Mansbridge et al. Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers.
Hotchin et al. Regulation of cell surface beta 1 integrin levels during keratinocyte terminal differentiation.
Blakytny et al. Altered molecular mechanisms of diabetic foot ulcers
Jarnagin et al. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.
Balza et al. Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts
Roy et al. Fibronectin overexpression in retinal microvessels of patients with diabetes.
Pinney et al. Human three‐dimensional fibroblast cultures express angiogenic activity
McNeil et al. Growth factors are released by mechanically wounded endothelial cells.
Terranova et al. Repopulation of dentin surfaces by periodontal ligament cells and endothelial cells: effect of basic fibroblast growth factor
Liu et al. Transforming growth factor-β regulates in vitro heart valve repair by activated valve interstitial cells
Yamamoto et al. Mast cells enhance contraction of three‐dimensional collagen lattices by fibroblasts by cell–cell interaction: role of stem cell factor/c‐kit
Asselman et al. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells
JPH07504650A (en) Inhibition of transforming growth factor β to prevent extracellular matrix accumulation
JP2016520068A (en) Wound healing and tissue engineering
Kay et al. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen.
EP3986430B1 (en) Methods of promoting vasculogenesis
Linnala et al. Transforming growth factor-beta regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells.
Takemura et al. Heparin‐binding EGF‐like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis
Mauch et al. Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three‐dimensional collagen gels